Handling and pathology reporting of adrenal gland specimens

European Urology

Volumn 45, Issue 6, 2004, Pages 722-729

  Scarpelli, M ^a   Algaba, F ^b   Kirkali, Z ^c   Van Poppel, H ^d  

^a UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

^b FUNDACIÓ PUIGVERT   (Spain)

^c DOKUZ EYLUL UNIVERSITY   (Turkey)

^d UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

Adrenal gland tumors; Pathology reporting; Sampling

Indexed keywords

ADRENAL BIOPSY; ADRENAL CANCER; ADRENAL DISEASE; ADRENAL GLAND; CANCER DIAGNOSIS; CANCER STAGING; CANCER SURGERY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; DISEASE SEVERITY; HUMAN; LABORATORY DIAGNOSIS; PATHOLOGIST; PHEOCHROMOCYTOMA; PRIORITY JOURNAL; REVIEW; TREATMENT OUTCOME; TUMOR CLASSIFICATION;

ADRENAL GLANDS; HUMANS; MEDICAL RECORDS; SPECIMEN HANDLING;

EID: 2442519190     PISSN: 03022838     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eururo.2003.12.006     Document Type: Review

References (39)

1. De Jong S.A. What's new in general surgery: endocrine. J. Am. Coll. Surg. 197(3):2003;436-443
2. Saeger W., Fassnacht M., Chita R., Prager G., Nies C., Lorenz K., et al. High Diagnostic accuracy of adrenal core biopsy: results of the german and austrian adrenal network multicenter trial in 220 consecutive patients. Hum. Pathol. 34:2003;180-186
3. Ambros P.F., Ambros I.M., Bernard J., Caron H., Favrot M., Delattre O. Application and definition of biological criteria to allow a refined treatment of localized neuroblastoma as part of the LNESG protocol. Med. Pediatr. Oncol. 25:1995;278
4. Tang C.K., Gray G.F. Adrenocortical neoplasms. Prognosis and morphology. Urology. 5:1975;691-695
5. Sasano H, Suzuki T, Moriya. Discerning malignancy in resected adrenocortical Neoplasms. Endocrine Pathol 2001;12(4):397-401.
6. Lack E.E. Recommendations for the reporting of tumours of the adrenal cortex and medulla. Association of Directors of Anatomic and Surgical Pathology. Virchows Arch. 435:1999;87-91
7. Granger P., Genest J. Autopsy study of adrenals in unselected normotensive and hypertensive patients. Can. Med. Assoc. J. 103:1970;34
8. Lack EE. Tumors of Adrenal gland and extra-adrenal paraganglia. Atlas of Tumor Pathology. AFIP; 1997.
9. Saeger W., Reinhard K., Rinhard C. Hyperplastic and tumorous lesions of the adrenals in an unselected autopsy series. Endocr. Pathol. 9(3):1998;235-239
10. Solcia E, Klöpel G, Sobin LH. Tumors of the adrenal cortex. In: Histological Typing of Endocrine Tumors. WHO International Histological Classification of Tumors, Second Edition. 2000, pp. 29-33.
11. Lack E.E., Travis W.D. Diagnostic problems in surgical pathology of the adrenal glands. Modern Pathol. 8(3):1995;312-331
12. Diaz-Cano S., de Miguel M., Blanes A., Tashjian R., Galera H., Wolfe H.J. Clonality as expression of distinctive cell kinetics patterns in nodular hyperplasias and adenomas of adrenal cortex. Am. J. Pathol. 156(1):2000;311-319
13. Weiss L.M. Comparative histopathologic study of 43 metastasizing and nonmetastasizing adrenocortical tumors. Am. J. Surg. Pathol. 8:1984;163-169
14. Hough A.J., Hollifield J.W., Page D.L., Hartmann W.H. Prognostic factors in adrenal cortex tumors: a mathematical analysis of clinical and morphological data. Am. J. Clin. Pathol. 72:1979;390-399
15. Van Slooten H.V., Schaberg A., Smeenk D., Meelenaar A.J. Morphologic characteristics of benign and malignant adrenocortical tumors. Cancer. 55:1985;766-773
16. Weiss L.M., Medeiros L.J., Vickery A.L. Pathologic features of prognostic significance in adrenocortical carcinoma. Am. J. Surg. Pathol. 13:1989;202-206
17. Aubert S., Wacrenier A., Leroy X., Devos P., Carnaille B., Proye C., et al. Weiss system revisited. A clinicopathologic and immunohistochemical study of 49 adrenocortical tumors. Am. J. Surg. Pathol. 26(12):2002;1612-1619
18. Renshaw A.A., Granter S.R. A comparison of A103 and Inhibin reactivity in adrenal cortical tumors: distinction from hepatocellular carcinoma and renal tumors. Mod. Pathol. 11(12):1998;1160-1164
19. Loy T.S., Phillips R.W., Linder C.L. A 103 immunostaining in the diagnosis of adrenal cortical tumors. An immunohistochemical study of 316 cases. Arch Pathol. Lab Med. 126:2002;170-172
20. Zhang P.J., Genega E.M., Tomaszewski J.E., Pasha T.L., LiVolsi V.A. The role of Calretinin, Inhibin, Melan-A, BCL-2 and C-Kit in differentiating adrenal cortical and medullary tumors: an immunohistochemical study. Mod. Pathol. 16(6):2003;591-597
21. Medeiros J.L., Weiss L.M. New developments in the pathologic diagnosis of adrenal cortical neoplasms. A review. Am. J. Clin. Pathol. 97:1992;73-83
22. Evans H. Vassilopoulou-Sellin. Adrenal Cortical Neoplasms. A Study of 56 cases. Am J Clin Pathol 1996;105:76-86.
23. Wajchenberg B.L., Pereira M.A.A., Medonca B.B., Latronico A.C., Carneiro P.C., Alves V.A.F., et al. Adrenocortical carcinoma. Clinical and Laboratory observations. Cancer. 88:2000;711-736
24. McFarlane D.A. Cancer of the adrenal cortex. The natural history, prognosis and treatment in a study of fifty-five cases. Ann. Royal Coll. Surg. Engl. 23:1958;155-186
25. Sullivan M., Boileau M., Hodges C.V. Adrenal cortical carcinoma. J. Urol. 120:1978;660-665
26. Wooten M.D., King D.K. Adrenal cortical carcinoma. Epidemiology and treatment with mitotane and a review of the literature. Cancer. 72:1993;3145-3155
27. Linnoila R.I., Keiser H.R., Steinberg S.M., Lack E.E. Histopathology of benign versus malignant sympathoadrenal paragangliomas. Clinicopathologic study of 120 cases including unusual histologic features. Hum. Pathol. 21:1990;1168-1180
28. Clarke M.R., Weyant R.J., Watson C.G., Carty S.E. Prognostic markers in pheochromocytoma. Hum. Pathol. 28:1998;522-526
29. Thompson LDL. Pheochromocytoma of the adrenal gland scaled score (PASS) to separate benign from malignant neoplasms. A clinicopathologic and immunophenotypic study of 100 cases. Am J Surg Pathol 2002;551-66.
30. Kubota Y., Nakada T., Sasagawa I., Yanai H., Itoh K. Elevated levels of telomerase activity in malignant pheochromocytoma. Cancer. 82:1998;176-179
31. Salmenkivi K., Haglund C., Arola J., Heikkila P. Increased expression of tenascin in pheochromocytomas correlates with malignancy. Am. J. Surg. Pathol. 25(11):2001;1419-1423
32. Favier J, Plouin PF, Corvol P, Gasc JM. Angiogenesis and vascular architecture in pheochromocytomas: distinctive traits in malignant tumors. Am J Pathol 2002;161(4):1235-12.
33. Kumaki N., Kajiwara H., Kameyama K., DeLellis R., Asa S.L., Osamura R.Y., et al. Prediction of malignant behavior of pheochromocytomas and paragangliomas using immunohistochemical techniques. Endocrine Pathol. 13(2):2002;149-156
34. Page D.L., Ruby S.G. Protocol for the examination of specimens from patients with malignant adrenal cortical tumors and pheochromocytomas. Arch. Pathol. Lab. Med. 124:2000;17-20
35. Management of the clinically inapparent adrenal mass (incidentaloma). National Institutes of Health. State-of-the-Science Conference statement, 2002 http://www.cap.org/cancerprotocols/protocols_index.htm.
36. Shimada H., Chatten J., Newton W.A., Sachs N., Hamoudi A.B., Chiba T. Histopathologic prognostic factors in neuroblastic tumors: defintion of subtypes of ganglioneuroblastoma and an age-linked classification of neuroblastomas. J. Natl. Cancer Inst. 73:1984;405-416
37. Shimada H., Ambros I.M., Denher L.P., Hata J., Joshi V.V., Roald B., et al. The International Neuroblastoma Pathology Classification (the Shimada system). Cancer. 86:1999;364-372
38. Shimada H., Ambros I.M., Denher L.P., Hata J., Joshi V.V., Roald B. Terminology and morphologic criteria of neuroblastic tumors. Cancer. 86:1999;349-363
39. Brodeur G.M., Pritchard J., Berthold F., Carlsen N.L., Castel V., Castelberry R.P., et al. Revisions of the international criteria for neuroblastoma diagnosis, staging and response to treatment. J. Clin. Oncol. 11(8):1993;1466-1477